Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Neuromyelitis Optica × 4-Aminopyridine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neuromyelitis Optica 1 Myelitis, Transverse 1 Myelitis 1

Interventions

eculizumab 3 ublituximab 1 ravulizumab 1 Sugars 1 LFB-R603 1 4-Aminopyridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02166346 2018-04-17

Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch)

Johns Hopkins University

Phase 2 Completed

24 enrolled 10 charts

Myelitis, Myelitis, Transverse, Neuromyelitis Optica

Data powered by HemOnc (CC BY 4.0) Colophon ⚡